Although it is encouraging to see the legal system to some degree catching up with drug company malfeasance, there are a number of problems with the criminal and civil cases brought by the Department of Justice against drug companies.

More articles like the one in the New York Times are needed to inform parents about the consequences of putting excessive pressure on their kids and readily giving them powerful psychiatric medications to improve their focus and their grades.

Traditionally pharma and medical device companies design health tools for health care professionals and in clinical settings. What's been missing is any thought about the end user: the patient.

If we are prepared to acknowledge the widespread bullying to which both science and sense are subject at the hands of the almighty dollar, we might commit ourselves to the systematic effort of distinguishing the two.

Tirades are, by their very nature, apt to gain a lot of attention and "go viral." They are dramatic. They are extreme, provocative, and full of intrigue. Hype sells. Unfortunately, much of the time -- it is wrong.

Last Friday, five months after receiving approval from the FDA, pharmacists finally began doling out the newest sleep aid to the groggy hordes.

FDA approval of Qnexa will represent a rather desperate measure at a desperate time for desperate individuals of a desperate society. So be it. But our desperate need to address this problem decisively is long overdue and should be the mother of far better invention than this.

It was not a great surprise that the FDA's new cephalosporin livestock rules have the Agribusiness Seal of Approval. It was Big Pharma and Agribusiness lobbying that killed its stronger cephalosporin rules issued four years after.

It's no secret that drug ads that sow hypochondria, raise health fears and "sell" diseases are often the most common -- and effective -- even when the drugs themselves are of questionable safety.